Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05962476 · ClinicalTrials.gov registry record · NA
Transcutaneous Vibro-Acoustic Therapy in Parkinson Disease
A NA study, sponsored by University of Michigan.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT05962476: Clinical Trial NA study, sponsored by University of Michigan.
NCT05962476 is a NA study that was terminated before completion, run by University of Michigan. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05962476, a NA study, was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
Small exploratory pilot study to assess effects of a transcutaneous vibro-acoustic therapy device (Apollo Neuro) in people with Parkinson's disease (PD).
Primary Outcome
Average heart rate variability during the night, as measured by Oura ring device (measured in s).
Interventions
- DEVICE Transcutaneous vibro-acoustic device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2023-08-09 |
| Est. Completion | 2023-08-09 |
| Phase | NA |
Why NCT05962476 stopped before completion
NCT05962476 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Transcutaneous vibro-acoustic device is the first listed.
NCT05962476 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05962476 about?
NCT05962476 is a clinical study titled "Transcutaneous Vibro-Acoustic Therapy in Parkinson Disease". Small exploratory pilot study to assess effects of a transcutaneous vibro-acoustic therapy device (Apollo Neuro) in people with Parkinson's disease (PD).
What is the current status of trial NCT05962476?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2023-08-09. Estimated completion is 2023-08-09.
What interventions are being tested in trial NCT05962476?
The interventions under investigation include: Transcutaneous vibro-acoustic device (DEVICE).
Who is sponsoring clinical trial NCT05962476?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05962476's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI